Smartleaf Asset Management LLC Uro Gen Pharma Ltd. Transaction History
Smartleaf Asset Management LLC
- $1.62 Trillion
- Q3 2025
A detailed history of Smartleaf Asset Management LLC transactions in Uro Gen Pharma Ltd. stock. As of the latest transaction made, Smartleaf Asset Management LLC holds 72 shares of URGN stock, worth $1,458. This represents 0.0% of its overall portfolio holdings.
Number of Shares
72Holding current value
$1,458% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding URGN
# of Institutions
166Shares Held
39.7MCall Options Held
2.06MPut Options Held
717K-
Rtw Investments, LP New York, NY4.54MShares$92 Million0.96% of portfolio
-
Toronto Dominion Bank Toronto, Ontario, A63.19MShares$64.6 Million0.08% of portfolio
-
Morgan Stanley New York, NY2.48MShares$50.2 Million0.0% of portfolio
-
Jefferies Financial Group Inc. New York, NY2.2MShares$44.5 Million0.27% of portfolio
-
Black Rock Inc. New York, NY2.19MShares$44.4 Million0.0% of portfolio
About UroGen Pharma Ltd.
- Ticker URGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 22,740,500
- Market Cap $460M
- Description
- UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...